Naproxen-associated linear IgA bullous dermatosis: Case report and review

Mayo Clinic Proceedings

Volumn 75, Issue 9, 2000, Pages 967-970

  Bouldin, Molly Bridges ^a   Glowers Webb, Holly E ^a   Davis, Jaime L ^b   McEvoy, Marian T ^a   Davis, Mark D P ^a  

^a MAYO CLINIC   (United States)

^b ALBERT LEA EYE CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NAPROXEN;

AGED; ANTIGENICITY; ARTHRALGIA; ARTICLE; BASEMENT MEMBRANE; BLISTER; BULLOUS DERMATITIS; CASE REPORT; COMORBIDITY; DRUG INDUCED DISEASE; HOSPITALIZATION; HUMAN; MALE; MOUTH MUCOSA;

EID: 0033827170     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.9.967     Document Type: Article

References (46)

1. Wojnarowska F. Marsden RA, Bhogal B, Black MM. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults: a comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol. 1988;I9:792-805.
2. Jablonska S, Chorzelski T. IgA linear dermatosis [in French]. Ann Dermatol Venereal. 1979; 106:651-655.
3. Camilleri M, Pace JL. Linear IgA bullous dermatosis induced by piroxicam. J Eur Acad Dermatol Venereal. 1998:10:70-72.
4. Gabrielsen TO, Staerfelt F, Thune PO. Drug-induced bullous dermatosis with linear IgA deposits along the basement membrane. Ada Derm Venereal. 1981;61:439-441.
5. Valsecchi R, Serra M, Tornaghi A, Cainelli T. Drug-induced bullous dermatosis with linear IgA [in Italian]. G haï Dermatol Venereal. 1982:117:221-223.
6. Paul C, Wolkenstein P, Prost C, et al. Drug-induced linear IgA disease: target antigens are heterogeneous. Br J Dermatol. 1997; 136:406-411.
7. Kuechle MK, Stegemeir E, Maynard B, Gibson LE, Leiferman KM, Peters MS. Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature. / Am Acad Dermatol. 1994:30:187-192.
8. Leigh G, Marsden RA, Wojnarowska F. Linear IgA dermatosis with severe arthralgia. Br J Dermatol. 1988;! 19:789-792.
9. Godfrey K, Wojnarowska F, Leonard J. Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors. Br J Dermatol. \990; 123:447-452.
10. Hayakawa K, Shiohara T, Yagita A, Nagashima M. Linear IgA bullous dermalosis associated with rheumatoid arthritis. J Am Acad Dermatol. 1992:26:110-113.
11. Janniger CK, Wiltz H, Schwartz RA, Kowalewski C, Lambert WC. Adult linear IgA bullous dermatosis: a polymorphic disorder. Cutis. 1990:45:37-42.
12. McEvoy MT, Connolly SM. Linear IgA dermatosis: association with malignancy. J Am Acad Dermatol. 1990;22:59-63.
13. Baden LA, Apovian C, Imber MJ, Dover JS. Vancomycin-induced linear IgA bullous dermatosis [letter]. Arch Dermatol. 1988:124: 1186-1188.
14. Carpenter S, Berg D, Sidhu-Malik N, Hall RP III, Rico MJ. Vancomycin-associated linear IgA dermatosis: a report of three cases. J Am Acad Dermatol. 1992:26:45-48.
15. Bitman LM, Grossman ME, Ross H. Bullous drug eruption treated with amputation: a challenging case of vancomycin-induced linear IgA disease. Arch Dermatol. 1996; 132:1289-1290.
16. Whitworth JM, Thomas I, Peltz SA, Sullivan BC, Wolf AH, Cytryn AS. Vancomycin-induced linear IgA bullous dermatosis (LABD). J Am Acad Dermatol. 1996;34:890-891.
17. Richards SS, Hall S, Yokel B, Whitmore SE. A bullous eruption in an elderly woman: vancomycin-associated linear IgA dermatosis (LAD). Arch Dermatol. 1995; 131:1447-1448, 1450-1451.
18. Geissmann C, Beylot-Barry M, Doutre MS, Beylot C. Drug-induced linear IgA bullous dermatosis [letter]. J Am Acad Dermatol. 1995;32:296.
19. Collier PM, Wojnarowska F. Drug-induced linear immunoglobulin A disease. Clin Dermatol. 1993; 11:529-533.
20. Klein LE, Shmunes E, Carter JB, Walsh MY. Linear IgA bullous dermatosis related to captopril treatment. Cutis. 1989;44:393-396.
21. McWhirter JD, Hashimoto K, Fayne S, Ito K. Linear IgA bullous dermatosis related to lithium carbonate. Arch Dermatol. 1987; 123: 1120-1122.
22. Argenyi ZB, Bergfeld WF, Valenzuela R, McMahon JT, Taylor JS. Adult linear IgA disease associated with an erythema multiformelike drug reaction. Cleve ClinJMed. 1987;54:445-450.
23. Tranvan A, Pezen DS, Medenica M, Michelson GC, Vogelzang N, Soltani KM. Interleukin-2 associated linear IgA bullous dermatosis. J Am Acad Dermatol. 1996;35:865-867.
24. Guillaume JC, Escudier B, Espagne E, et al. Bullous dermatosis with linear IgA deposits along the basement membrane during treatment with gamma Interferon and interleukin-2 [in French]. Ann Dermatol Venereal. 1990;! 17:899-902.
25. Primka EJ III, Liranzo MO, Bergfeld WF, Dijkstra JW. Amiodarone-induced linear IgA disease. J Am Acad Dermatol. 1994; 31:809-811.
26. Wakelin SH, Wojnarowska F. Linear IgA disease exacerbated by topical iodine preparations [letter]. Br J Dermatol. 1994; 131:918.
27. Combemale P, Gavaud C, Cozzani E, Nicolas JF, Guennoc B, Dusseau JY. Linear IgA dermatosis induced by penicillin G [in French]. Ann Dermatol Venereal. 1993; 120:847-848.
28. Vaatainen N, Fraki JE, Hyvonen M, Neittaanmaki H. Purpura with a linear epidermo-dermal deposition of IgA. Ada Derm Venereal. 1983;63:169-170.
29. Boffety B, Soheire J, Venencie PY, et al. Dermatoses bulleuse a IgA linéaire. J Dermatol Paris. 1981:53-53a.
30. Espagne E, Prost C, Chosidow O, Saiag P, Revuz J, Roujeau JC. Linear IgA drug-induced dermatosis: report of 3 cases [in French]. Ann Dermatol Venereal. 1990;! 17:898-899.
31. Smith JB, Hogan DJ. Factors that exacerbate linear IgA disease [letter]. J Am Acad Dermatol. 1995;33:320-321.
32. Petit D, Borradori L, Rybojad M, Morel P. Linear IgA bullous dermatosis after heart transplantation. J Am Acad Dermatol. 1990;22:851.
33. Tonev S, Vasileva S, Kadurina M. Depot sulfonamid associated linear IgA bullous dermatosis with erythema multiforme-like clinical features. J Eur Acad Dermatol Venereal. 1998; 11:165-168.
34. Cerottini JP, Ricci C, Guggisberg D, Panizzon RG. Drug-induced linear IgA bullous dermatosis probably induced by furosemide. J Am Ac-ad Dermatol. 1999;41:103-105.
35. Pellicano R, Lomuto M. Cozzani E, lannantuono M, De Simone C. Linear IgA bullous dermatosis after contact with sodium hypochlorite. Dermatology. 1997; 194:284-286.
36. Kano Y, Kokaji T, Shiohara T. Linear IgA bullous dermatosis in a patient with acute lymphocytic leukemia: possible involvement of granulocyte colony-stimulating factor. Eur J Dermatol. 1999; 9:122-125.
37. Bernstein EF, Schuster M. Linear IgA bullous dermatosis associated with vancomycin [letter]. Ann Intern Med. 1998; 129:508-509.
38. Chorzelski TP, Jablonska S, Beutner EH, Wilson BD. Linear IgA bullous dermatosis. In: Beutner EH, Chorzelski TP, Kurnar V, eds. Immunopathology of the Skin. 3rd ed. New York, NY: John Wiley & Sons; 1987:407-420.
39. Leonard JN, Haffenden GP, Ring NP, Fry L. Linear IgA bullous dermatosis in adults-the St Mary's view. In: Beutner EH, Chorzelski TP, Kumar V, eds. Immunopathology of the Skin. 3rd ed. New York, NY: John Wiley & Sons; 1987:421-429.
40. Leonard JN, Haffenden GP, Ring NP, et al. Linear IgA disease in adults. BrJ Dermatol. 1982;107:301-316.
41. Wilson BD, Beutner EH, Kumar V, Chorzelski TP, Jablonska S. Linear IgA bullous dermatosis: an immunologically defined disease. In! ] Dermatol. 1985;24:569-574.
42. Leonard JN, Wright P, Williams DM, et al. The relationship between linear IgA disease and benign mucous membrane pemphigoid. Br J Dermatol. 1984; 110:307-314.
43. Peters MS, Rogers RS. Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone. / Am Acad Dermatol. 1989;20:761-770.
44. Camilleri M, Pace JL. Drug-induced linear immunoglobulin-A bullous dermatosis. Clin Dermatol. 1998:16:389-391.
45. Horiguchi Y, Toda K, Okamoto H, Imamura S. Immunoelectron microscopic observations in a case of linear IgA bullous dermatosis of childhood. J Am Acad Dermatol. 1986; 14:593-599.
46. Zone JJ, Taylor TB, Kadunce DP, Meyer LJ. Identification of the cutaneous basement membrane zone antigen and isolation of antibody in linear immunoglobulin A bullous dermatosis. / Clin Invest. 1990:85:812-820.